+7 (499) 340 10 14

The Sphere of Application Has Extended

The Ministry of Healthcare of the Russian Federation approved amendments to Hepa-Merz prescribing information. It has become necessary as during studies of pharmacological properties of the drug new properties were discovered – improvement of asthenic, dyspeptic and pain syndromes, as well as correction of overweight in steatosis and steatohepatitis.

Until recently the drug was used to treat only acute and chronic liver diseases accompanied with hypermammoniemia. Today the sphere of its use was significantly expanded, as now it has been clinically proven that Hepa-Merz may normalize hepatic function and improve the quality of life of patients, both in severe disorders (e.g. cirrhosis) and at the early stages of pathologies.

LABMGMU LABMGMU +7 (499) 340 10 14 info@labmgmu.ru 119435, Moscow, Malaya Pirogovskay str. 13-1, floor 4